Plasma proadrenomedullin (proADM) is a promising biomarker to foresee sickness seriousness in local area gained pneumonia (CAP). Urinary biomarkers offer benefits over blood, including simplicity of assortment. We assessed the relationship between urinary proADM and illness seriousness in pediatric CAP. Outcomes were examined using logistic regression within the cohort with suspected CAP and in a subset with radiographic CAP.